Adenocarcinoma, Pancreatic
1 clinical trials · Condition
◉ Watch Adenocarcinoma, Pancreatic
| Record | Firm | Date |
|---|---|---|
| Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors (NCT04034238) | National Cancer Institute (NCI) | 2019-08-29 |
Track Adenocarcinoma, Pancreatic automatically
Every clearance here is in the API, with alerts when new ones post.